Telix Pharmaceuticals
NEWS
Pharmaceutical companies are combining antibodies with radioisotopes in a bid to more precisely deliver radiation to cancers and tumors.
Neuroscience-focused Rapport Therapeutics and radiopharma developer Telix Pharma announced their respective plans Friday for initial public offerings on the Nasdaq for undisclosed dollar amounts.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
It was yet another busy week for clinical trial news. Here’s a look.
Heidelberg Pharma AG announced that it has received a milestone payment of 250 TUSD from its cooperation partner Telix Pharmaceuticals Limited, Melbourne, Australia,.
JOBS
IN THE PRESS